Search research articles
Contact Us
Filters
Showing results (61-70 of 221) with videos related to
Page
of 23
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
September 19, 2023
Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis
Daniele Caliendo, Anna Puca, Luigi Lavorgna, et al.
Parkinsonism & Related Disorders
|
September 14, 2016
Caffeine consumption and the 4-year progression of de novo Parkinson's disease
Marcello Moccia, Roberto Erro, Marina Picillo, et al.
Brain Sciences
|
April 3, 2021
Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis
Maria Petracca, Giuseppe Pontillo, Marcello Moccia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 27, 2015
Season of birth and Parkinson's disease: possible relationship?
Raffaele Palladino, Marcello Moccia, Teresa De Pascale, et al.
Biomarker Insights
|
November 3, 2025
Advancing Clinical Use of Neurofilament Light Chain: Translational Insights From Research to Routine Practice
Evelina La Civita, Valerio Nicolella, Mariano Fiorenza, et al.
Journal of the Neurological Sciences
|
June 11, 2022
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series
Marcello Moccia, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Multiple Sclerosis and Related Disorders
|
January 10, 2022
Monitoring of safety and effectiveness of cladribine in multiple sclerosis patients over 50 years
Giulio Disanto, Marcello Moccia, Rosaria Sacco, et al.
Frontiers in Neurology
|
July 7, 2020
Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials
Marcello Moccia, Roberta Lanzillo, Martina Petruzzo, et al.
Expert Opinion on Drug Safety
|
July 26, 2021
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies
Antonio Riccardo Buonomo, Giulio Viceconte, Emanuela Zappulo, et al.
Multiple Sclerosis and Related Disorders
|
April 22, 2017
Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study
Luigi Lavorgna, Marcello Moccia, Antonio Russo, et al.
Page
of 23
Search research articles
Search
Showing results (61-70 of 221) with videos related to
Sort By:
Page
of 23
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
September 19, 2023
Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis
Daniele Caliendo, Anna Puca, Luigi Lavorgna, et al.
Parkinsonism & Related Disorders
|
September 14, 2016
Caffeine consumption and the 4-year progression of de novo Parkinson's disease
Marcello Moccia, Roberto Erro, Marina Picillo, et al.
Brain Sciences
|
April 3, 2021
Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis
Maria Petracca, Giuseppe Pontillo, Marcello Moccia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 27, 2015
Season of birth and Parkinson's disease: possible relationship?
Raffaele Palladino, Marcello Moccia, Teresa De Pascale, et al.
Biomarker Insights
|
November 3, 2025
Advancing Clinical Use of Neurofilament Light Chain: Translational Insights From Research to Routine Practice
Evelina La Civita, Valerio Nicolella, Mariano Fiorenza, et al.
Journal of the Neurological Sciences
|
June 11, 2022
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series
Marcello Moccia, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Multiple Sclerosis and Related Disorders
|
January 10, 2022
Monitoring of safety and effectiveness of cladribine in multiple sclerosis patients over 50 years
Giulio Disanto, Marcello Moccia, Rosaria Sacco, et al.
Frontiers in Neurology
|
July 7, 2020
Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials
Marcello Moccia, Roberta Lanzillo, Martina Petruzzo, et al.
Expert Opinion on Drug Safety
|
July 26, 2021
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies
Antonio Riccardo Buonomo, Giulio Viceconte, Emanuela Zappulo, et al.
Multiple Sclerosis and Related Disorders
|
April 22, 2017
Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study
Luigi Lavorgna, Marcello Moccia, Antonio Russo, et al.
Page
of 23